TherapeuticsMD (TXMD) Other Operating Expenses (2010 - 2026)

TherapeuticsMD's Other Operating Expenses history runs 17 years deep, the most recent figure standing at $94000.0 for Q1 2026.

• Quarterly Other Operating Expenses fell 48.63% year-over-year to $94000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $471000.0 (down 74.22% YoY) and the FY2025 annual result came in at $560000.0, down 68.49% from the prior year.
• Other Operating Expenses was $94000.0 for Q1 2026 at TherapeuticsMD, down from $153000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $143.4 million in Q2 2022 and bottomed at -$18.9 million in Q1 2022.
• A 5-year average of $10.6 million and a median of $133000.0 in 2024 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 7029.99% in 2022, while the deepest fall reached 1021.71% in 2022.
• TherapeuticsMD's Other Operating Expenses stood at $9.8 million in 2022, then sank by 93.49% to $637000.0 in 2023, then plunged by 83.2% to $107000.0 in 2024, then jumped by 42.99% to $153000.0 in 2025, then plunged by 38.56% to $94000.0 in 2026.
• Business Quant data shows TXMD's Other Operating Expenses at $94000.0 in Q1 2026, $153000.0 in Q4 2025, and $128000.0 in Q3 2025.